RecruitingNot ApplicableNCT05833048

Rectus Sheath Block in Cardiac Surgery


Sponsor

Icahn School of Medicine at Mount Sinai

Enrollment

75 participants

Start Date

Jul 29, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This is a prospective, randomized study. The purpose of this study is to evaluate the effect of post-surgical pain control of a type of peripheral nerve block, Rectus Sheath Block. 1. Does the rectus sheath block decrease opioid consumption postoperatively after cardiac surgery? 2. Does the rectus sheath block decrease VAS pain scores postoperatively after cardiac surgery? Study participants will be assigned to receive either rectus sheath block or no block.


Eligibility

Min Age: 18 YearsMax Age: 85 Years

Inclusion Criteria4

  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Adults 18-85 years old
  • Scheduled to undergo cardiac procedures involving chest tubes
  • Male or female

Exclusion Criteria6

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • ASA class V
  • Urgent or emergent surgery
  • Contraindications to administration of local anesthesia (e.g. local anesthetic allergy)
  • History of substance abuse or chronic opioid use
  • Patient refusal or inability to consent

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURERectus sheath block

Participants will receive an ultrasound guided rectus sheath block with local anesthetic


Locations(1)

Mount Sinai Morningside Hospital Center

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05833048


Related Trials